2008
DOI: 10.1002/cyto.a.20695
|View full text |Cite
|
Sign up to set email alerts
|

Where new approaches can stem from: Focus on stem cell identification

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
10
0
1

Year Published

2009
2009
2011
2011

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 11 publications
1
10
0
1
Order By: Relevance
“…The determination of the origin and identity of SCs together with their niches in adult tissue also provides important information on their participation in endogenous tissue regeneration and their possible applications as pluri-or multipotent cells in cellular regeneration therapy (6,7,(27)(28)(29)(30)(31)(32)(33). Evidence accumulated in the last few years show that the adult macro-and microvessels contain multi-or pluripotent SCs, including MSCs, and/or pericytes, as well as hemopoietic SCs, and lineage committed progenitors, such as vascular walls endothelial progenitor and Sca-1 1 smooth muscle progenitor cells (6,7,23,(29)(30)(31)(33)(34)(35)(36).…”
Section: Discussionmentioning
confidence: 99%
“…The determination of the origin and identity of SCs together with their niches in adult tissue also provides important information on their participation in endogenous tissue regeneration and their possible applications as pluri-or multipotent cells in cellular regeneration therapy (6,7,(27)(28)(29)(30)(31)(32)(33). Evidence accumulated in the last few years show that the adult macro-and microvessels contain multi-or pluripotent SCs, including MSCs, and/or pericytes, as well as hemopoietic SCs, and lineage committed progenitors, such as vascular walls endothelial progenitor and Sca-1 1 smooth muscle progenitor cells (6,7,23,(29)(30)(31)(33)(34)(35)(36).…”
Section: Discussionmentioning
confidence: 99%
“…In most cases a combination of a hematopoietic stem cell marker, like CD34, CD117 (cKit), or CD133, with a marker for endothelial cells, like vascular endothelial growth factor receptor 2 (KDR) or Ve-cadherin, are used to identify EPCs (summarized in Refs. 1,28,81). The combination of CD34 ϩ /KDR ϩ is the most often used set for quantification of EPCs in the current literature.…”
Section: Definition and Detectionmentioning
confidence: 99%
“…On the basis of these new data, we updated our previous phenotypic table by a set of seven new cell types isolated from additional organs and include a set of additional markers not present in the earlier overview (2). Therefore, we asked all authors to revisit the table and upgrade their part either by own data or based on additional literature, as necessary.…”
mentioning
confidence: 99%